330 related articles for article (PubMed ID: 25113877)
21. New chiral derivatives of xanthones: synthesis and investigation of enantioselectivity as inhibitors of growth of human tumor cell lines.
Fernandes C; Masawang K; Tiritan ME; Sousa E; de Lima V; Afonso C; Bousbaa H; Sudprasert W; Pedro M; Pinto MM
Bioorg Med Chem; 2014 Feb; 22(3):1049-62. PubMed ID: 24411197
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and antiproliferative activity studies of novel 1,2,3-triazole-dithiocarbamate-urea hybrids.
Duan YC; Zheng YC; Li XC; Wang MM; Ye XW; Guan YY; Liu GZ; Zheng JX; Liu HM
Eur J Med Chem; 2013 Jun; 64():99-110. PubMed ID: 23644193
[TBL] [Abstract][Full Text] [Related]
23. Bromoalkoxyxanthones as promising antitumor agents: synthesis, crystal structure and effect on human tumor cell lines.
Sousa E; Paiva A; Nazareth N; Gales L; Damas AM; Nascimento MS; Pinto M
Eur J Med Chem; 2009 Sep; 44(9):3830-5. PubMed ID: 19428155
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and in vitro antitumor activities of xanthone derivatives containing 1,4-disubstituted-1,2,3-triazole moiety.
Zou Y; Zhao Q; Hu H; Hu L; Yu S; Xu M; Wu Q
Arch Pharm Res; 2012 Dec; 35(12):2093-104. PubMed ID: 23263803
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and evaluation of gambogic acid derivatives as antitumor agents. Part III.
Guo XK; Sun HP; Shen S; Sun Y; Xie FL; Tao L; Guo QL; Jiang C; You QD
Chem Biodivers; 2013 Jan; 10(1):73-85. PubMed ID: 23341209
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis and biological evaluation of [1,2,3]triazolo[4,5-d]pyrimidine derivatives possessing a hydrazone moiety as antiproliferative agents.
Li ZH; Yang DX; Geng PF; Zhang J; Wei HM; Hu B; Guo Q; Zhang XH; Guo WG; Zhao B; Yu B; Ma LY; Liu HM
Eur J Med Chem; 2016 Nov; 124():967-980. PubMed ID: 27771599
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and anticancer activity of novel dihydrobenzofuro[4,5-b][1,8]naphthyridin-6-one derivatives.
Kang JA; Yang Z; Lee JY; De U; Kim TH; Park JY; Lee HJ; Park YJ; Chun P; Kim HS; Jeong LS; Moon HR
Bioorg Med Chem Lett; 2011 Oct; 21(19):5730-4. PubMed ID: 21885273
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of new xanthone analogues and their biological activity test--cytotoxicity, topoisomerase II inhibition, and DNA cross-linking study.
Woo S; Jung J; Lee C; Kwon Y; Na Y
Bioorg Med Chem Lett; 2007 Mar; 17(5):1163-6. PubMed ID: 17194586
[TBL] [Abstract][Full Text] [Related]
29. Design and synthesis of novel 1,2,3-triazole-pyrimidine-urea hybrids as potential anticancer agents.
Ma LY; Wang B; Pang LP; Zhang M; Wang SQ; Zheng YC; Shao KP; Xue DQ; Liu HM
Bioorg Med Chem Lett; 2015 Mar; 25(5):1124-8. PubMed ID: 25655718
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, biological evaluation, and molecular docking study of 3-(3'-heteroatom substituted-2'-hydroxy-1'-propyloxy) xanthone analogues as novel topoisomerase IIα catalytic inhibitor.
Jun KY; Lee EY; Jung MJ; Lee OH; Lee ES; Park Choo HY; Na Y; Kwon Y
Eur J Med Chem; 2011 Jun; 46(6):1964-71. PubMed ID: 21419530
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and structure-activity relationships of novel 4-phenoxyquinoline derivatives containing pyridazinone moiety as potential antitumor agents.
Zhou S; Liao H; He C; Dou Y; Jiang M; Ren L; Zhao Y; Gong P
Eur J Med Chem; 2014 Aug; 83():581-93. PubMed ID: 24996144
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and in vitro Evaluation of the Anticancer Potential of New Aminoalkanol Derivatives of Xanthone.
Szkaradek N; Sypniewski D; Waszkielewicz AM; Gunia-Krzyżak A; Galilejczyk A; Gałka S; Marona H; Bednarek I
Anticancer Agents Med Chem; 2016; 16(12):1587-1604. PubMed ID: 27039927
[TBL] [Abstract][Full Text] [Related]
33. Click chemistry inspired synthesis and bioevaluation of novel triazolyl derivatives of osthol as potent cytotoxic agents.
Farooq S; Shakeel-u-Rehman ; Hussain A; Hamid A; Qurishi MA; Koul S
Eur J Med Chem; 2014 Sep; 84():545-54. PubMed ID: 25062005
[TBL] [Abstract][Full Text] [Related]
34. Design and synthesis of novel 2'-hydroxy group substituted 2-pyridone derivatives as anticancer agents.
Lv Z; Zhang Y; Zhang M; Chen H; Sun Z; Geng D; Niu C; Li K
Eur J Med Chem; 2013 Sep; 67():447-53. PubMed ID: 23920246
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of novel pyrimidine-benzimidazol hybrids as potential anticancer agents.
Shao KP; Zhang XY; Chen PJ; Xue DQ; He P; Ma LY; Zheng JX; Zhang QR; Liu HM
Bioorg Med Chem Lett; 2014 Aug; 24(16):3877-81. PubMed ID: 25001482
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, and cytotoxic and antiplatelet activities of oxime- and methyloxime-containing flavone, isoflavone, and xanthone derivatives.
Wang TC; Chen IL; Lu CM; Kuo DH; Liao CH
Chem Biodivers; 2005 Feb; 2(2):253-63. PubMed ID: 17191978
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and pharmacological evaluation of novel pyrrolizine derivatives as potential anticancer agents.
Gouda AM; Abdelazeem AH; Arafa el-SA; Abdellatif KR
Bioorg Chem; 2014 Apr; 53():1-7. PubMed ID: 24462996
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis and biological evaluation of novel thieno[3,2-d]pyrimidine derivatives containing diaryl urea moiety as potent antitumor agents.
Liu Z; Wang Y; Lin H; Zuo D; Wang L; Zhao Y; Gong P
Eur J Med Chem; 2014 Oct; 85():215-27. PubMed ID: 25086238
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, and SAR analysis of cytotoxic sinapyl alcohol derivatives.
Zou HB; Dong SY; Zhou CX; Hu LH; Wu YH; Li HB; Gong JX; Sun LL; Wu XM; Bai H; Fan BT; Hao XJ; Stöckigt J; Zhao Y
Bioorg Med Chem; 2006 Mar; 14(6):2060-71. PubMed ID: 16303311
[TBL] [Abstract][Full Text] [Related]
40. The conversion of oridonin to spirolactone-type or enmein-type diterpenoid: synthesis and biological evaluation of ent-6,7-seco-oridonin derivatives as novel potential anticancer agents.
Wang L; Li D; Xu S; Cai H; Yao H; Zhang Y; Jiang J; Xu J
Eur J Med Chem; 2012 Jun; 52():242-50. PubMed ID: 22483090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
